human milk human milk Search Results


96
ATCC l reuteri atcc pta 6475
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
L Reuteri Atcc Pta 6475, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l reuteri atcc pta 6475/product/ATCC
Average 96 stars, based on 1 article reviews
l reuteri atcc pta 6475 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc human egf
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Human Egf, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human egf/product/Gold Biotechnology Inc
Average 94 stars, based on 1 article reviews
human egf - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc number: 1150-04-100
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Number: 1150 04 100, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/number: 1150-04-100/product/Gold Biotechnology Inc
Average 94 stars, based on 1 article reviews
number: 1150-04-100 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

92
Lee Biosolutions human breast milk
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Human Breast Milk, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human breast milk/product/Lee Biosolutions
Average 92 stars, based on 1 article reviews
human breast milk - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Biosynth Carbosynth linkage key s sulfate α α α α α biosynth sialylated human milk oligosaccharides biosynth neutral human milk oligosaccharides supplementary
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Linkage Key S Sulfate α α α α α Biosynth Sialylated Human Milk Oligosaccharides Biosynth Neutral Human Milk Oligosaccharides Supplementary, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/linkage key s sulfate α α α α α biosynth sialylated human milk oligosaccharides biosynth neutral human milk oligosaccharides supplementary/product/Biosynth Carbosynth
Average 93 stars, based on 1 article reviews
linkage key s sulfate α α α α α biosynth sialylated human milk oligosaccharides biosynth neutral human milk oligosaccharides supplementary - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Cusabio elisa kits
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Elisa Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits/product/Cusabio
Average 90 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

91
Boster Bio s100 β
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
S100 β, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/s100 β/product/Boster Bio
Average 91 stars, based on 1 article reviews
s100 β - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

93
Innovative Research Inc human breast milk
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Human Breast Milk, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human breast milk/product/Innovative Research Inc
Average 93 stars, based on 1 article reviews
human breast milk - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc egf
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Egf, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/egf/product/Gold Biotechnology Inc
Average 94 stars, based on 1 article reviews
egf - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

85
Lee Biosolutions human apo 343 lactoferrin
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Human Apo 343 Lactoferrin, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human apo 343 lactoferrin/product/Lee Biosolutions
Average 85 stars, based on 1 article reviews
human apo 343 lactoferrin - by Bioz Stars, 2026-04
85/100 stars
  Buy from Supplier

90
Verlag GmbH milk and dairy products in human nutrition
Limosilactobacillus reuteri DSM 17938 + ATCC <t>PTA</t> <t>6475</t> and improvement on irritable bowel syndrome symptoms.
Milk And Dairy Products In Human Nutrition, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/milk and dairy products in human nutrition/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
milk and dairy products in human nutrition - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
BioGaia Inc human breast milk-derived lr17938
Lactobacillus reuteri DSM 17938 <t>(LR17938)</t> increased survival rate of mouse pups with necrotizing enterocolitis (NEC). Mice (8–10 days old) were separated from their mothers and housed in an incubator. NEC was induced by formula feeding + stress (FS) with hypoxia (5% O2-95% N2 for 10 min) and cold exposure (4°C for 5 min) twice daily for 4 days (indicated by arrows). Live animals were counted on each day for calculation of survival rate. Mice were euthanized on day 5 after NEC protocol (indicated by ×), and tissues were collected. In some cases, pups in the FS group were euthanized on day 3 or 4, if they were in pain, demonstrated labored respirations, or exhibited abdominal distension or gastrointestinal bleeding, to collect tissues for histological analysis and to calculate survival rate. LR17938 [106 colony-forming units (CFU)·g body wt−1·day−1] was added to the formula for treatment (FS + 17938). LR17938 reduced mortality rate on day 5 compared with FS without probiotic. *P = 0.027.
Human Breast Milk Derived Lr17938, supplied by BioGaia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human breast milk-derived lr17938/product/BioGaia Inc
Average 90 stars, based on 1 article reviews
human breast milk-derived lr17938 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Limosilactobacillus reuteri DSM 17938 + ATCC PTA 6475 and improvement on irritable bowel syndrome symptoms.

Journal: Frontiers in Gastroenterology

Article Title: Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial

doi: 10.3389/fgstr.2023.1296048

Figure Lengend Snippet: Limosilactobacillus reuteri DSM 17938 + ATCC PTA 6475 and improvement on irritable bowel syndrome symptoms.

Article Snippet: Limosilactobacillus reuteri DSM 17938 and L. reuteri ATCC PTA 6475 are two strains of L. reuteri species, with specific modes of action as identified in vitro and in animal models, showing clear anti-inflammatory potential as well as intestinal epithelial integrity and gut homeostasis capabilities.

Techniques:

Lactobacillus reuteri DSM 17938 (LR17938) increased survival rate of mouse pups with necrotizing enterocolitis (NEC). Mice (8–10 days old) were separated from their mothers and housed in an incubator. NEC was induced by formula feeding + stress (FS) with hypoxia (5% O2-95% N2 for 10 min) and cold exposure (4°C for 5 min) twice daily for 4 days (indicated by arrows). Live animals were counted on each day for calculation of survival rate. Mice were euthanized on day 5 after NEC protocol (indicated by ×), and tissues were collected. In some cases, pups in the FS group were euthanized on day 3 or 4, if they were in pain, demonstrated labored respirations, or exhibited abdominal distension or gastrointestinal bleeding, to collect tissues for histological analysis and to calculate survival rate. LR17938 [106 colony-forming units (CFU)·g body wt−1·day−1] was added to the formula for treatment (FS + 17938). LR17938 reduced mortality rate on day 5 compared with FS without probiotic. *P = 0.027.

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3 + regulatory T cells in a mouse model of necrotizing enterocolitis

doi: 10.1152/ajpgi.00038.2014

Figure Lengend Snippet: Lactobacillus reuteri DSM 17938 (LR17938) increased survival rate of mouse pups with necrotizing enterocolitis (NEC). Mice (8–10 days old) were separated from their mothers and housed in an incubator. NEC was induced by formula feeding + stress (FS) with hypoxia (5% O2-95% N2 for 10 min) and cold exposure (4°C for 5 min) twice daily for 4 days (indicated by arrows). Live animals were counted on each day for calculation of survival rate. Mice were euthanized on day 5 after NEC protocol (indicated by ×), and tissues were collected. In some cases, pups in the FS group were euthanized on day 3 or 4, if they were in pain, demonstrated labored respirations, or exhibited abdominal distension or gastrointestinal bleeding, to collect tissues for histological analysis and to calculate survival rate. LR17938 [106 colony-forming units (CFU)·g body wt−1·day−1] was added to the formula for treatment (FS + 17938). LR17938 reduced mortality rate on day 5 compared with FS without probiotic. *P = 0.027.

Article Snippet: Probiotic LR17938 Preparation Human breast milk-derived LR17938 was provided by Biogaia (Stockholm, Sweden).

Techniques:

LR17938 reduced incidence and severity of NEC. A: representative intestinal histological changes in dam-fed, dam-fed + 17938, FS (NEC protocol), and FS + 17938 mice. Ileal tissues were stained with hematoxylin and eosin. Magnification ×200. Red arrows, villous core separations in animals with NEC; black arrows, normal villi in ileal tissue from dam-fed or FS + 17938 mice. B: number of animals with normal histology (NEC scores <2) and with NEC (NEC scores ≥2). n, Number of live animals from which tissue samples could be collected. Terminal ileum of each mouse was harvested at day 5 (or day 3 or 4 for some samples in the FS group). %, Incidence of NEC. *P < 0.05 vs. FS. C: FS and FS + 17938 groups with NEC scores of 2 and 3. *P < 0.05 vs. FS. LR17938 reduced NEC histological injury.

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3 + regulatory T cells in a mouse model of necrotizing enterocolitis

doi: 10.1152/ajpgi.00038.2014

Figure Lengend Snippet: LR17938 reduced incidence and severity of NEC. A: representative intestinal histological changes in dam-fed, dam-fed + 17938, FS (NEC protocol), and FS + 17938 mice. Ileal tissues were stained with hematoxylin and eosin. Magnification ×200. Red arrows, villous core separations in animals with NEC; black arrows, normal villi in ileal tissue from dam-fed or FS + 17938 mice. B: number of animals with normal histology (NEC scores <2) and with NEC (NEC scores ≥2). n, Number of live animals from which tissue samples could be collected. Terminal ileum of each mouse was harvested at day 5 (or day 3 or 4 for some samples in the FS group). %, Incidence of NEC. *P < 0.05 vs. FS. C: FS and FS + 17938 groups with NEC scores of 2 and 3. *P < 0.05 vs. FS. LR17938 reduced NEC histological injury.

Article Snippet: Probiotic LR17938 Preparation Human breast milk-derived LR17938 was provided by Biogaia (Stockholm, Sweden).

Techniques: Staining

Increased IL-1β levels in intestine of mice subjected to the NEC protocol and the modifying effect of LR17938 treatment. Cytokine levels in tissue lysates were examined using Meso Scale Discovery cytokine assay; n = 8–12 mice per group. Comparisons showed significant differences: P < 0.01 (FS vs. dam) and P < 0.05 (FS + 17938 vs. FS).

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3 + regulatory T cells in a mouse model of necrotizing enterocolitis

doi: 10.1152/ajpgi.00038.2014

Figure Lengend Snippet: Increased IL-1β levels in intestine of mice subjected to the NEC protocol and the modifying effect of LR17938 treatment. Cytokine levels in tissue lysates were examined using Meso Scale Discovery cytokine assay; n = 8–12 mice per group. Comparisons showed significant differences: P < 0.01 (FS vs. dam) and P < 0.05 (FS + 17938 vs. FS).

Article Snippet: Probiotic LR17938 Preparation Human breast milk-derived LR17938 was provided by Biogaia (Stockholm, Sweden).

Techniques: Cytokine Assay

LR17938 reversed frequency of CD4+Foxp3+ regulatory T (Treg) cells in terminal ileum and mesenteric lymph nodes (MLNs) of mice with NEC. A: representative flow cytometric plots from terminal ileum of dam-fed mice with initial gating on lymphocyte population on the left forward scatter (FSC)-side scatter (SSC) plot (left), followed by gating on CD4+ T cells [middle; x-axis: CD4-peridinin-chlorophyll proteins (CD4-PerCP/Cy5.5); y-axis: CD–phycoerythrin (CD8-PE)], and Foxp3+ Treg cells within the group of CD8−CD4+ T cells (right; x-axis: CD4-PerCP/Cy5.5; y-axis: Foxp3-Alexa Fluor 647). B and C: frequency (%) of CD4+Foxp3+ Treg cells in terminal ileum and MLNs. n, Number of live animals from which sufficient cell numbers were obtained from tissues for analysis. FS vs. dam: P < 0.01 (B) or P < 0.001 (C); FS vs. FS + 17938: P < 0.01 (B and C); FS vs. FS + Lactobacillus acidophilus DDS (La DDS; B and C): P > 0.05. D: percentage of Treg cells in terminal ileum of dam-fed + LR17938 and dam-fed mice (P < 0.001).

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3 + regulatory T cells in a mouse model of necrotizing enterocolitis

doi: 10.1152/ajpgi.00038.2014

Figure Lengend Snippet: LR17938 reversed frequency of CD4+Foxp3+ regulatory T (Treg) cells in terminal ileum and mesenteric lymph nodes (MLNs) of mice with NEC. A: representative flow cytometric plots from terminal ileum of dam-fed mice with initial gating on lymphocyte population on the left forward scatter (FSC)-side scatter (SSC) plot (left), followed by gating on CD4+ T cells [middle; x-axis: CD4-peridinin-chlorophyll proteins (CD4-PerCP/Cy5.5); y-axis: CD–phycoerythrin (CD8-PE)], and Foxp3+ Treg cells within the group of CD8−CD4+ T cells (right; x-axis: CD4-PerCP/Cy5.5; y-axis: Foxp3-Alexa Fluor 647). B and C: frequency (%) of CD4+Foxp3+ Treg cells in terminal ileum and MLNs. n, Number of live animals from which sufficient cell numbers were obtained from tissues for analysis. FS vs. dam: P < 0.01 (B) or P < 0.001 (C); FS vs. FS + 17938: P < 0.01 (B and C); FS vs. FS + Lactobacillus acidophilus DDS (La DDS; B and C): P > 0.05. D: percentage of Treg cells in terminal ileum of dam-fed + LR17938 and dam-fed mice (P < 0.001).

Article Snippet: Probiotic LR17938 Preparation Human breast milk-derived LR17938 was provided by Biogaia (Stockholm, Sweden).

Techniques:

Increased Treg cells induced by LR17938 during the NEC protocol in terminal ileum of mice were predominantly thymus-derived Treg cells with Helios expression. Percentage of Helios+ cells within CD4+Foxp3+ Treg cells is shown. *Undetectable due to low numbers of Treg cells in the ileum. There were no differences between FS + 17938 and dam-fed mice. All groups demonstrated high Helios expression in ∼75% of Treg cells.

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3 + regulatory T cells in a mouse model of necrotizing enterocolitis

doi: 10.1152/ajpgi.00038.2014

Figure Lengend Snippet: Increased Treg cells induced by LR17938 during the NEC protocol in terminal ileum of mice were predominantly thymus-derived Treg cells with Helios expression. Percentage of Helios+ cells within CD4+Foxp3+ Treg cells is shown. *Undetectable due to low numbers of Treg cells in the ileum. There were no differences between FS + 17938 and dam-fed mice. All groups demonstrated high Helios expression in ∼75% of Treg cells.

Article Snippet: Probiotic LR17938 Preparation Human breast milk-derived LR17938 was provided by Biogaia (Stockholm, Sweden).

Techniques: Derivative Assay, Expressing

LR17938 reduced the increased activated effector/memory T (Tem) cells in intestinal mucosa of mice with NEC. A: representative flow cytometric plots from terminal ileum of mice. Population of CD4+Foxp3− non-Treg cells was initially defined (dotted rectangle in 1st left plot) according to expression of CD4 and Foxp3 (x-axis: CD4-PerCP/Cy5.5; y-axis: Foxp3-Alexa Fluor 647). Two different effector T cells were further characterized in the non-Treg cell population on the basis of expression of CD44 and CD45RB (x-axis: CD44-FITC; y-axis: CD45RB-PE). Percentages of T cells with phenotypes of CD44+CD45RBlo (Tem) and CD44+CD45RBhi (transitional effector T) (rectangle in the 2nd left plot) are indicated. Representative plots show percentages of Tem and transitional effector T cells in dam-fed, dam-fed + 17938, FS, FS + 17938, and FS + La DDS mice. B and C: frequency (%) of Tem cells and transitional effector T cells in ileum of mice among the different groups. n, Number of live animals from which sufficient cell numbers were successfully obtained from tissues for analysis. Significant P values for multigroup comparisons are shown. *P < 0.05 FS + 17938 vs. dam.

Journal: American Journal of Physiology - Gastrointestinal and Liver Physiology

Article Title: Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3 + regulatory T cells in a mouse model of necrotizing enterocolitis

doi: 10.1152/ajpgi.00038.2014

Figure Lengend Snippet: LR17938 reduced the increased activated effector/memory T (Tem) cells in intestinal mucosa of mice with NEC. A: representative flow cytometric plots from terminal ileum of mice. Population of CD4+Foxp3− non-Treg cells was initially defined (dotted rectangle in 1st left plot) according to expression of CD4 and Foxp3 (x-axis: CD4-PerCP/Cy5.5; y-axis: Foxp3-Alexa Fluor 647). Two different effector T cells were further characterized in the non-Treg cell population on the basis of expression of CD44 and CD45RB (x-axis: CD44-FITC; y-axis: CD45RB-PE). Percentages of T cells with phenotypes of CD44+CD45RBlo (Tem) and CD44+CD45RBhi (transitional effector T) (rectangle in the 2nd left plot) are indicated. Representative plots show percentages of Tem and transitional effector T cells in dam-fed, dam-fed + 17938, FS, FS + 17938, and FS + La DDS mice. B and C: frequency (%) of Tem cells and transitional effector T cells in ileum of mice among the different groups. n, Number of live animals from which sufficient cell numbers were successfully obtained from tissues for analysis. Significant P values for multigroup comparisons are shown. *P < 0.05 FS + 17938 vs. dam.

Article Snippet: Probiotic LR17938 Preparation Human breast milk-derived LR17938 was provided by Biogaia (Stockholm, Sweden).

Techniques: Expressing